173 related articles for article (PubMed ID: 33500248)
1. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis.
Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S
Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma.
Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R
Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
[TBL] [Abstract][Full Text] [Related]
5. MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition.
He A; He S; Huang C; Chen Z; Wu Y; Gong Y; Li X; Zhou L
Aging (Albany NY); 2020 Jan; 12(2):1465-1487. PubMed ID: 31978894
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Regulatory Network for LINC00472 in Clear Cell Renal Cell Carcinoma.
Gao S; Wang Z
J Healthc Eng; 2021; 2021():3533608. PubMed ID: 34221297
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma.
Bhat NS; Colden M; Dar AA; Saini S; Arora P; Shahryari V; Yamamura S; Tanaka Y; Kato T; Majid S; Dahiya R
Mol Cancer Ther; 2017 Dec; 16(12):2840-2848. PubMed ID: 28802251
[TBL] [Abstract][Full Text] [Related]
8. FOXD1 regulates cell division in clear cell renal cell carcinoma.
Bond KH; Fetting JL; Lary CW; Emery IF; Oxburgh L
BMC Cancer; 2021 Mar; 21(1):312. PubMed ID: 33761914
[TBL] [Abstract][Full Text] [Related]
9. EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway.
Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
[TBL] [Abstract][Full Text] [Related]
10. Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.
Borges Dos Reis R; Shu X; Ye Y; Borregales L; Karam JA; Adibi M; Wu X; Reis LO; Wood CG
Clin Genitourin Cancer; 2024 Feb; 22(1):e156-e162.e4. PubMed ID: 37945405
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
[TBL] [Abstract][Full Text] [Related]
12. Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma.
Parol-Kulczyk M; Durślewicz J; Blonkowska L; Wujec R; Gzil A; Piątkowska D; Ligmanowska J; Grzanka D
J Pathol Clin Res; 2024 Mar; 10(2):e12365. PubMed ID: 38436543
[TBL] [Abstract][Full Text] [Related]
13. LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma.
Meng K; Lu S; Li YY; Hu LL; Zhang J; Cao Y; Wang Y; Zhang CZ; He QY
EMBO Rep; 2023 Jun; 24(6):e56282. PubMed ID: 37009826
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis.
Le LN; Choi C; Han JA; Kim EB; Trinh VN; Kim YJ; Ryu S
Front Oncol; 2024; 14():1371934. PubMed ID: 38680858
[TBL] [Abstract][Full Text] [Related]
15. Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2.
Tan M; Pan Q; Wu Q; Li J; Wang J
Front Med; 2023 Jun; 17(3):503-517. PubMed ID: 36790589
[TBL] [Abstract][Full Text] [Related]
16. Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
Zeng B; Wan R; Chang K; Li J; Zhang X; Shi G; Ye D; Xu F
Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426605
[TBL] [Abstract][Full Text] [Related]
17. BTN3A3 inhibits clear cell renal cell carcinoma progression by regulating the ROS/MAPK pathway via interacting with RPS3A.
Li Z; Zhang M; Chen S; Dong W; Zong R; Wang Y; Fan S
Cell Signal; 2023 Dec; 112():110914. PubMed ID: 37806541
[TBL] [Abstract][Full Text] [Related]
18. Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.
Fu L; Minton DR; Zhang T; Nanus DM; Gudas LJ
Mol Cancer Res; 2015 May; 13(5):870-8. PubMed ID: 25715653
[TBL] [Abstract][Full Text] [Related]
19. Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKCδ and c-Src signaling pathway.
Horng CT; Shieh PC; Tan TW; Yang WH; Tang CH
Int J Mol Sci; 2014 Jul; 15(7):11760-72. PubMed ID: 24992595
[TBL] [Abstract][Full Text] [Related]
20. LINK-A: unveiling its functional role and clinical significance in human tumors.
Liao B; Wang J; Xie Y; Luo H; Min J
Front Cell Dev Biol; 2024; 12():1354726. PubMed ID: 38645412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
